The Prognostic Value of Mean Platelet Volume to Platelet Count Ratio in Older Patients with Non-St Elevation Acute Coronary Syndrome Receiving Primary Percutaneous Coronary Intervention: a Retrospective Study.

Xiaogiang Sun,Heng Li,Yankun Zhang,Feng He,Chengzhi Lu
DOI: https://doi.org/10.23736/s0026-4725.18.04836-3
2019-01-01
Abstract:BACKGROUND: The aim of this study was to investigate the value of the mean platelet volume to platelet count (MPV/P) ratio for predicting in-hospital and long-term cardiac mortality in older non-ST elevation-acute coronary syndrome (NSTE-ACS) patients after primary percutaneous coronary intervention (PCI). METHODS: We retrospectively reviewed 452 older NSTE-ACS patients who received primary PCI. The patients were divided into two groups based on MPV/P ratios: high MPV/P group (N.=150) defined as a value in the third tertile (>0.056628) and low MPV/P group (N.=302) in the lower two tertiles (<= 0.056628). Clinical outcomes included non-fatal reinfarction, heart failure, and cardiac mortality. RESULTS: Multivariate analyses showed that high MPV/P and MPV values were independent predictors of cardiac mortality. The in-hospital cardiac mortality of the high MPV/P group was higher than the low MPV/P group (1.3% vs. 14.7%, P<0.001). The rates of heart failure and cardiac mortality in one year were significantly higher in the high MPV/P group compared to the low MPV/P group (P<0.05). The cut-off value of MPV/P for predicting cardiac death was 0.067107, with a sensitivity of 0.707 and a specificity of 0.868. MPV/P was superior to MPV (z=9.235, P<0.001) for predicting cardiac mortality. CONCLUSIONS: High MPV/P and MPV values are independent predictors of cardiac mortality in older patients with NSTE-ACS receive primary PCI. Moreover, MPV/P is better than MPV for predicting cardiac mortality.
What problem does this paper attempt to address?